Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

× No keyword cloud information.

23 in total

1. Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures.

Authors: J M Pepin; F Simon; A Dussault; G Collin; M C Dazza; F Brun-Vezinet
Journal: J Clin Microbiol Date: 1992-11 Impact factor: 5.948

2. Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.

Authors: R L Saltzman; M R Quirk; M C Jordan
Journal: J Clin Invest Date: 1988-01 Impact factor: 14.808

3. 9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice.

Authors: E J Wilson; D N Medearis; L A Hansen; R H Rubin
Journal: Antimicrob Agents Chemother Date: 1987-07 Impact factor: 5.191

4. Kaposi's sarcoma of the conjunctiva and CMV-retinitis in AIDS.

Authors: O H Visser; P J Bos
Journal: Doc Ophthalmol Date: 1986-12-30 Impact factor: 2.379

5. Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus.

Authors: G Andrei; R Snoeck; D Schols; P Goubau; J Desmyter; E De Clercq
Journal: Eur J Clin Microbiol Infect Dis Date: 1991-12 Impact factor: 3.267

Review 6. Viral skin infections: diagnosis and treatment considerations.

Authors: Kyoung C Park; Won S Han
Journal: Drugs Date: 2002 Impact factor: 9.546

Review 7. Ganciclovir. A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS.

Authors: C M Perry; R Davis
Journal: Pharmacoeconomics Date: 1997-08 Impact factor: 4.981

Review 8. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.

Authors: A K Field; K K Biron
Journal: Clin Microbiol Rev Date: 1994-01 Impact factor: 26.132

9. Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients.

Authors: M A Slavin; R R Bindra; C A Gleaves; M B Pettinger; R A Bowden
Journal: Antimicrob Agents Chemother Date: 1993-06 Impact factor: 5.191

10. Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients.

Authors: C E Chamberlain; S R Penzak; R M Alfaro; R Wesley; C E Daniels; D Hale; A D Kirk; R B Mannon
Journal: Am J Transplant Date: 2008-04-29 Impact factor: 8.086